Enhanced glomerular transfection by BMP7 gene nanocarriers inhibits CKD and promotes SOX9-dependent tubule regeneration

Renal fibrosis and loss of kidney function are key characteristics of chronic kidney disease (CKD). To address the lack of effective treatments, multifunctional layer-by-layer (LbL) assembled polymeric gene-carrier nanoparticles (PCHS-NP) are prepared to realize preferential accumulation and retention within renal glomerular cells, thereby effectively leveraging cortically localized structures for the synthesis and paracrine secretion of the antifibrotic growth factor, bone morphogenetic protein-7 (BMP7). PCHS-NP had stable homogenous morphologies, kidney-targeting functionality, antioxidative effects, and high transfection efficiency. In unilateral ureteral obstruction (UUO)-induced renal fibrosis, a single systemic injection of PCHS-NP prevents tubular atrophy and interstitial fibrosis, and the resultant tissue microenvironment is more conducive to tubular regeneration driven by the upregulation of proliferative SOX9-expressing tubular cells. In longer-term folic acid (FA)-induced renal fibrosis, we show that early, late, and repeat systemic injections restore kidney health and function. This study indicates that PCHS-NP accomplish a promising therapeutic option for the treatment of CKD. Conclusion: Layer-by-layer assembled multifunctional polymer-based gene carrier nanoparticles are prepared as highly homogenous and stable kidney-targeting nanomedicines. Decoration with antioxidative triserine facilitates renal mesangium accumulation, whilst reducing liver uptake. Gene delivery promotes mesangial paracrine BMP7 production after a single systemic injection. The combined antioxidative and antifibrotic effects are conducive for prevention and reversal of chronic kidney disease. • Layer-by-layer assembled nanoparticles were highly homogenous and stable. • Triserine decorations facilitated kidney uptake whilst reducing liver uptake. • Traceable Cy5-loaded nanoparticles revealed renal glomerular cell accumulation. • Elevated paracrine BMP7 production was realized after one systemic injection. • Antioxidative and antifibrotic effects were conducive for renal regeneration.

Authors

Institutions

Publication Details

Journal
Nano Today
Published
2024-11-04
DOI
https://doi.org/10.1016/j.nantod.2024.102545
Citations
3
Primary Topic
Renal and related cancers
Type
article
Field-Weighted Citation Impact
0.70

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Enhanced glomerular transfection by BMP7 gene nanocarriers inhibits CKD and promotes SOX9-dependent tubule regeneration

Ruifang Li, Deling Kong, Adam C. Midgley, Jiangyue Yu et al.
3 citations
Nano Today
Renal and related cancers
0.70
article

Enhanced glomerular transfection by BMP7 gene nanocarriers inhibits CKD and promotes SOX9-dependent tubule regeneration

Ruifang Li, Deling Kong, Adam C. Midgley, Jiangyue Yu, Xinyan Zhang, Yao Chen, Zhen Liu, Jia Li, Xueyuan Bai, Lili Zhao, Yifan Tai, Yanrong Wang
article en
3 citations

Abstract

Renal fibrosis and loss of kidney function are key characteristics of chronic kidney disease (CKD). To address the lack of effective treatments, multifunctional layer-by-layer (LbL) assembled polymeric gene-carrier nanoparticles (PCHS-NP) are prepared to realize preferential accumulation and retention within renal glomerular cells, thereby effectively leveraging cortically localized structures for the synthesis and paracrine secretion of the antifibrotic growth factor, bone morphogenetic protein-7 (BMP7). PCHS-NP had stable homogenous morphologies, kidney-targeting functionality, antioxidative effects, and high transfection efficiency. In unilateral ureteral obstruction (UUO)-induced renal fibrosis, a single systemic injection of PCHS-NP prevents tubular atrophy and interstitial fibrosis, and the resultant tissue microenvironment is more conducive to tubular regeneration driven by the upregulation of proliferative SOX9-expressing tubular cells. In longer-term folic acid (FA)-induced renal fibrosis, we show that early, late, and repeat systemic injections restore kidney health and function. This study indicates that PCHS-NP accomplish a promising therapeutic option for the treatment of CKD. Conclusion: Layer-by-layer assembled multifunctional polymer-based gene carrier nanoparticles are prepared as highly homogenous and stable kidney-targeting nanomedicines. Decoration with antioxidative triserine facilitates renal mesangium accumulation, whilst reducing liver uptake. Gene delivery promotes mesangial paracrine BMP7 production after a single systemic injection. The combined antioxidative and antifibrotic effects are conducive for prevention and reversal of chronic kidney disease. • Layer-by-layer assembled nanoparticles were highly homogenous and stable. • Triserine decorations facilitated kidney uptake whilst reducing liver uptake. • Traceable Cy5-loaded nanoparticles revealed renal glomerular cell accumulation. • Elevated paracrine BMP7 production was realized after one systemic injection. • Antioxidative and antifibrotic effects were conducive for renal regeneration.

Nano TodayVol. 59
National Kidney Foundation (US), Nankai University (CN), Tianjin People's Hospital (CN), National Clinical Research (US), Kementerian Pendidikan Malaysia (MY)
National Natural Science Foundation of China
Zero hunger
Openalex Percentile: Top 29%
Renal and related cancers
0.70
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.